LENALIDOMID DEVATIS
Capsule, hard, 25mg
RxActive license
Active substance (INN)
lenalidomide
Pharmaceutical form
Pharmaceutical formCapsule, hard
Strength25mg
PackagingUkupno 21 kapsula tvrda u blisteru (3x7) u kartonskoj kutiji
ManufacturerDevatis GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L04AX04)
Marketing authorization holderDRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU "MAACPHARM"
Authorization dateMarch 5, 2026
Analogs in Montenegro
18Other medicines with the same active substance
LENALIDOMID ALKALOIDRx
Capsule, hard, 5mgLENALIDOMID ALKALOIDRx
Capsule, hard, 10mgLENALIDOMID ALKALOIDRx
Capsule, hard, 15mgLENALIDOMID ALKALOIDRx
Capsule, hard, 25mgLENALIDOMID DEVATISRx
Capsule, hard, 5mgLENALIDOMID DEVATISRx
Capsule, hard, 7.5mgLENALIDOMID DEVATISRx
Capsule, hard, 15mgLENALIDOMID DEVATISRx
Capsule, hard, 2.5mgLENALIDOMID DEVATISRx
Capsule, hard, 10mgLENALIDOMIDE ACCORDRestricted
Capsule, hard, 10mgLENALIDOMIDE ACCORDRestricted
Capsule, hard, 25mgLENALIDOMIDE GRINDEKSRx
Capsule, hard, 10mgLENALIDOMIDE GRINDEKSRx
Capsule, hard, 25mgREVLIMIDRx
Capsule, hard, 10mgREVLIMIDRx
Capsule, hard, 25mgREVLIMIDRx
Capsule, hard, 5mgREVLIMIDRx
Capsule, hard, 15mgREVLIMIDRx
Capsule, hard, 2.5mgSource: CInMED register